Search

The superiority of radiotherapy for treating Stage 2A testicular seminoma has been confirmed by a new study. Radiation should now be recommended to avoid present uncertainties—under which chemot

Data showing that whole brain radiotherapy should not be used in patients whose non-small cell lung cancer has metastasized to the brain were reported at the European Respiratory Society 2016 congress

Atrial fibrillation is prevented by exercise and life-long endurance athletes do not face the same elevated risks of stroke and heart disease from the condition as sedentary patients. Leisure and eve

When targeting lung tumors there is a risk of exposing upper parts of the heart unnecessarily to toxic levels of radiation. This can potentially be avoided by more bespoke levels of radiation field c

Although breast conserving therapy has proved of equivalent efficacy to mastectomy in many patients with early breast cancer, mastectomy was associated with longer survival among those with HER2 posit

AMSTERDAM, Netherlands—Some patients with breast cancer could soon be treated with surgery and targeted drugs without the need for chemotherapy—according to findings reported at the 2016 European Brea

The Audio Journal of Oncology tracks down the half dozen leading stories breaking in Turin at ESTRO 2016—the annual meeting of the European Society for Radiotherapy and Oncology. Nicolle Rekers MSc.,

BARCELONA—A new pencil beam scanning proton delivery technique—rescanning—could help limit the dose of radiation to surrounding tissues and organs by compensating for tumor motion in the chest caused

BARCELONA—A radiotherapy dose of more than 54 Gy improved survival in children with localized cerebral ependymoma in a large multicenter study from France that looked at the role of age, grade and dos

BARCELONA—For children with intracranial ependymoma and measurable residue after first- or second-line surgery, a hypofractionated radiotherapy boost was feasible and improved local control—in a study

BARCELONA—A sub-group analysis of a phase-III randomized study looking at women with early breast cancer found that patients aged 70 years or older who were treated with accelerated partial breast irr

BARCELONA—In patients with previously irradiated locally recurrent prostate cancer, salvage high-dose-rate brachytherapy (HDRB) was an effective and safe treatment option. The 3rd ESTRO Forum (April 2